---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-227025"
form_type: "8-K"
ticker: "CLYM"
cik: "0001768446"
company_name: "Climb Bio, Inc."
filed_at: "2025-10-01T23:59:59+00:00"
generated_at: "2026-05-17T05:06:29.129917+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Climb Bio appoints Susan Altschuller as CFO, grants 600,000 stock options

## Summary
- Appointed Susan Altschuller, Ph.D., MBA, as CFO and Treasurer effective Oct 1, 2025; previously CFO at Cerevel and ImmunoGen.
- Base salary $510,000/year; eligible for annual bonus up to 40% of base.
- Received option to purchase 600,000 shares under 2025 Inducement Plan; vesting 25% on one-year anniversary then monthly.
- Board amended Inducement Plan to increase reserved shares from 1.25M to 2.0M.
- Cindy Driscoll steps down as principal financial officer but continues as principal accounting officer.

## SEC filing metadata
- accession: 0001193125-25-227025
- form_type: 8-K
- ticker: CLYM
- cik: 0001768446
- company_name: Climb Bio, Inc.
- filed_at: 2025-10-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1768446/000119312525227025/0001193125-25-227025-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1768446/000119312525227025/d33819d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-227025
- JSON: https://secwatch.observer/filing/0001193125-25-227025.json
- Plain text: https://secwatch.observer/filing/0001193125-25-227025.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.